Similar articles

• The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.

  Lee KT, Lee DH, Yoo BM. Lee KT, et al. Pancreas. 2008 Nov;37(4):445-8. doi: 10.1097/MPA.0b013e3181733721. Pancreas. 2008. PMID: 18953260 Clinical Trial.
• Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.

  Deenadayalu VP, Blaut U, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Temkit M, Lehman GA, Sherman S. Deenadayalu VP, et al. J Clin Gastroenterol. 2008 Nov-Dec;42(10):1103-9. doi: 10.1097/MCG.0b013e318159cbd1. J Clin Gastroenterol. 2008. PMID: 18936645 Clinical Trial.
• Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.

  Choi CW, Kang DH, Kim GH, Eum JS, Lee SM, Song GA, Kim DU, Kim ID, Cho M. Choi CW, et al. Gastrointest Endosc. 2009 Apr;69(4):e11-8. doi: 10.1016/j.gie.2008.10.046. Gastrointest Endosc. 2009. PMID: 19327467 Clinical Trial.
• Antibiotic prophylaxis in acute necrotizing pancreatitis revisited.

  Segarra-Newnham M, Hough A. Segarra-Newnham M, et al. Ann Pharmacother. 2009 Sep;43(9):1486-95. doi: 10.1345/aph.1M153. Epub 2009 Aug 18. Ann Pharmacother. 2009. PMID: 19690227 Review.
• Diagnosis and treatment of acute pancreatitis: the position statement of the Italian Association for the study of the pancreas.

  Pezzilli R, Uomo G, Zerbi A, Gabbrielli A, Frulloni L, De Rai P, Delle Fave G, Di Carlo V; Italian Association for the Study of the Pancreas Study Group. Pezzilli R, et al. Dig Liver Dis. 2008 Oct;40(10):803-8. doi: 10.1016/j.dld.2008.02.019. Epub 2008 Apr 2. Dig Liver Dis. 2008. PMID: 18387862